搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella paratyphi A Protein CyaY (cyaY) CSB-YP473043SWT
CSB-EP473043SWT
CSB-BP473043SWT
CSB-MP473043SWT
CSB-EP473043SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Protein FdhE (fdhE) CSB-YP473044SWT
CSB-EP473044SWT
CSB-BP473044SWT
CSB-MP473044SWT
CSB-EP473044SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A HTH-type transcriptional activator rhaR (rhaR) CSB-YP473045SWT
CSB-EP473045SWT
CSB-BP473045SWT
CSB-MP473045SWT
CSB-EP473045SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A ATP-dependent protease subunit HslV (hslV) CSB-YP473046SWT
CSB-EP473046SWT
CSB-BP473046SWT
CSB-MP473046SWT
CSB-EP473046SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A HTH-type transcriptional repressor fabR (fabR) CSB-YP473047SWT
CSB-EP473047SWT
CSB-BP473047SWT
CSB-MP473047SWT
CSB-EP473047SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP473048SWT
CSB-EP473048SWT
CSB-BP473048SWT
CSB-MP473048SWT
CSB-EP473048SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Cytochrome c-552 (nrfA) CSB-YP473049SWT
CSB-EP473049SWT
CSB-BP473049SWT
CSB-MP473049SWT
CSB-EP473049SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Electron transport complex protein RnfB (rnfB) CSB-YP473050SWT
CSB-EP473050SWT
CSB-BP473050SWT
CSB-MP473050SWT
CSB-EP473050SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A 60 kDa chaperonin (groL), partial CSB-YP473051SWT
CSB-EP473051SWT
CSB-BP473051SWT
CSB-MP473051SWT
CSB-EP473051SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Probable L-ascorbate-6-phosphate lactonase ulaG (ulaG) CSB-YP473052SWT
CSB-EP473052SWT
CSB-BP473052SWT
CSB-MP473052SWT
CSB-EP473052SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Primosomal replication protein n (priB) CSB-YP473053SWT
CSB-EP473053SWT
CSB-BP473053SWT
CSB-MP473053SWT
CSB-EP473053SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A UPF0442 protein yjjB (yjjB), partial CSB-YP473054SWT1
CSB-EP473054SWT1
CSB-BP473054SWT1
CSB-MP473054SWT1
CSB-EP473054SWT1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Bis (5'-nucleosyl)-tetraphosphatase, symmetrical CSB-YP473055SWT
CSB-EP473055SWT
CSB-BP473055SWT
CSB-MP473055SWT
CSB-EP473055SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Probable crotonobetaine/carnitine-CoA ligase (caiC), partial CSB-YP473056SWT
CSB-EP473056SWT
CSB-BP473056SWT
CSB-MP473056SWT
CSB-EP473056SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Aspartate 1-decarboxylase (panD) CSB-YP473057SWT
CSB-EP473057SWT
CSB-BP473057SWT
CSB-MP473057SWT
CSB-EP473057SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP473058SWT
CSB-EP473058SWT
CSB-BP473058SWT
CSB-MP473058SWT
CSB-EP473058SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A UPF0289 protein yacF (yacF) CSB-YP473059SWT
CSB-EP473059SWT
CSB-BP473059SWT
CSB-MP473059SWT
CSB-EP473059SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi A Chaperone protein DnaK (dnaK), partial CSB-YP473060SWT
CSB-EP473060SWT
CSB-BP473060SWT
CSB-MP473060SWT
CSB-EP473060SWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized amino-acid permease C460.01c (SPBC460.01c), partial CSB-YP473061SXV
CSB-EP473061SXV
CSB-BP473061SXV
CSB-MP473061SXV
CSB-EP473061SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Mitochondrial nucleoid factor 1 (Mnf1) CSB-YP473062RA
CSB-EP473062RA
CSB-BP473062RA
CSB-MP473062RA
CSB-EP473062RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>